Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings

Pregabalin is a gamma-aminobutyric acid (GABA) analogue, used to treat neuropathic pain and epilepsy. Pregabalin was registered in Australia in 2005, and subsidized publically in 2013. We aimed to describe Australian patterns of pregabalin use and intentional poisoning, and identify people potentially at high risk of misuse.Population-based retrospective cohort study of dispensings in the 10% sample of Australian Pharmaceutical Benefits Scheme...